by: Parent Project Muscular DystrophyProsensa Update on Drisapersen (March 2014)
Prosensa presented a status update on Drisapersen and its follow-on compounds in a patient focused webinar hosted by United Parent Projects Muscular Dystrophy (UPPMD) on Tuesday, March 25th at 1 PM ET.
The webinar was presented by Giles Campion MD, Chief Medical Officer and Senior Vice-‐President R&D of Prosensa and featured the following guest speakers:
- Craig Campbell MD MSc FRCPC, Head of Section of Pediatric Neurology at London Health Sciences Centre, Associate Professor at Shulich School of Medicine of Western University, Associate Scientist at Child Health Research Institute
- Craig M. McDonald MD, Professor and Chair of Physical Medicine & Rehabilitation, Professor of Pediatrics at University of California Davis School of Medicine
